Literature DB >> 19769701

Lack of laboratory assessment of severe hyponatraemia is associated with detrimental clinical outcomes in hospitalised patients.

M Whyte1, C Down, J Miell, M Crook.   

Abstract

OBJECTIVE: Increased mortality with severe hyponatraemia is well known. What is less clear is the mortality risk according to the pattern of the developing hyponatraemia and whether this may be affected by the intervention of the clinician.
METHODS: From our laboratory database, we retrospectively collected data of a 12-month period of adult patients with severe hyponatraemia (< or = 120 mmol/l). One hundred and thirteen patients were identified. Normonatraemic controls (n = 113) were identified by plasma sodium of 135 mmol/l over the same period, and whose nadir during hospitalisation was > or = 130 mmol/l. Results are mean +/- SD unless stated otherwise. Duration of hospitalisation and clinical outcomes was confirmed from hospital records.
RESULTS: The mean nadir plasma sodium of the hyponatraemic group was 116.0 +/- 4.4 mmol/l and 134.0 +/- 2.8 mmol/l in controls. Although the hyponatraemic patients were younger than controls (65.8 +/- 18.4 vs. 72.3 +/- 14.9 years; p = 0.004), they had higher mortality (24 vs. 7, p = 0.002) and longer hospitalisation than controls: median (IQR), 12 (7-22) vs. 7 (3-16.5) days (p < 0.001). A total of 55 patients developed severe hyponatraemia following admission. This subgroup comprised a higher proportion of surgical patients (23.6% vs. 1.7%, p < 0.001) than those with severe hyponatraemia on admission. Furthermore, both mortality (n = 17 vs. n = 7; p = 0.02) and duration of hospitalisation, median 19 days (IQR 10-35) vs. 9.5 (5-15) days (p < 0.001), were greater. Failure to measure plasma and urinary osmolalities was associated with increased mortality.
CONCLUSIONS: Severe hyponatraemia is associated with prolonged admission and increased mortality compared with normonatraemic patients. Progressive hyponatraemia following admission incurs a higher risk of death. This may represent illness-severity, inappropriate management or inadequate investigation.

Entities:  

Mesh:

Year:  2009        PMID: 19769701     DOI: 10.1111/j.1742-1241.2009.02037.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  9 in total

Review 1.  SIAD: practical recommendations for diagnosis and management.

Authors:  M Cuesta; A Garrahy; C J Thompson
Journal:  J Endocrinol Invest       Date:  2016-04-19       Impact factor: 4.256

2.  A descriptive study of hyponatremia in a tertiary care hospital of Eastern India.

Authors:  Nandini Chatterjee; Nilanjan Sengupta; Chanchal Das; Atanu Roy Chowdhuri; Ashis Kumar Basu; Salil Kumar Pal
Journal:  Indian J Endocrinol Metab       Date:  2012-03

3.  Hyponatremia during hospitalization and in-hospital mortality in patients hospitalized from heart failure.

Authors:  S Saepudin; Patrick A Ball; Hana Morrissey
Journal:  BMC Cardiovasc Disord       Date:  2015-08-14       Impact factor: 2.298

4.  Multicentre study of investigation and management of inpatient hyponatraemia in the UK.

Authors:  Ploutarchos Tzoulis; Rhys Evans; Agnieszka Falinska; Maria Barnard; Tricia Tan; Emma Woolman; Rebecca Leyland; Nick Martin; Rebecca Edwards; Rebecca Scott; Kalyan Gurazada; Marie Parsons; Devaki Nair; Bernard Khoo; Pierre Marc Bouloux
Journal:  Postgrad Med J       Date:  2014-11-14       Impact factor: 2.401

5.  Prognosis of patients with severe hyponatraemia is related not only to hyponatraemia but also to comorbidities and to medical management: results of an observational retrospective study.

Authors:  Thierry Krummel; Eric Prinz; Marie-Astrid Metten; Claire Borni-Duval; Dorothée Bazin-Kara; Emmanuelle Charlin; Jean-Marc Lessinger; Thierry Hannedouche
Journal:  BMC Nephrol       Date:  2016-10-22       Impact factor: 2.388

6.  Do the etiology of hyponatremia and serum sodium levels affect the length of hospital stay in geriatric patients with hyponatremia?

Authors:  Salih Baser; Cakmak Nuray Yılmaz; Emin Gemcioglu
Journal:  J Med Biochem       Date:  2022-02-02       Impact factor: 3.402

7.  Prevalence of adrenal insufficiency among patients with euvolemic hyponatremia.

Authors:  Amit Kumar; Maria Ghosh; Jubbin Jagan Jacob
Journal:  Endocr Connect       Date:  2021-12-16       Impact factor: 3.335

8.  Hyponatremia in Melioidosis: Analysis of 10-year Data from a Hospital-Based Registry.

Authors:  Indu Ramachandra Rao; Tushar Shaw; Ravindra Attur Prabhu; Vandana Kalwaje Eshwara; Shankar Prasad Nagaraju; Dharshan Rangaswamy; Srinivas Vinayak Shenoy; Mohan Varadanayakanahalli Bhojaraja; Chiranjay Mukhopadhyay
Journal:  J Glob Infect Dis       Date:  2022-04-14

9.  Moderate hyponatremia is associated with increased risk of mortality: evidence from a meta-analysis.

Authors:  Giovanni Corona; Corinna Giuliani; Gabriele Parenti; Dario Norello; Joseph G Verbalis; Gianni Forti; Mario Maggi; Alessandro Peri
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.